best in its class (from businessweek), page-2

Edwards lifescience may be of interest to those that trade the us market! There are two medical-device companies we're excited about. One, Edwards Lifesciences (EW), will soon reveal late-stage clinical trials for a new heart valve technology. For people who have a diseased aortic valve, this technology wouldn't require open heart surgery. The second, HeartWare International (HTWR), has the best technology for what's called a ventricular assist device and is basically a heart pump. In a world where a substantial number of people have heart failureand there aren't enough heart transplants to go aroundthere's going to be a big market for this over the next five to seven years. While the device isn't available in the U.S. yet, its technology looks best in class.